First, they showed that TDO-expressing U87 glioma cells cultured with allogeneic peripheral blood mononuclear cells (PBMC) suppressed T-cell proliferation, an effect that was abolished by TDO knockdown. Here, TDO2 is linked to central nervous system cancer.